Jiankun International Berhad Bilan de santé

Santé financière contrôle des critères 4/6

Jiankun International Berhad possède un total de capitaux propres de MYR83.5M et une dette totale de MYR3.0M, ce qui porte son ratio d'endettement à 3.6%. Son actif total et son passif total sont MYR123.7M et de MYR40.2M.

Informations clés

3.6%

Ratio d'endettement

RM 3.04m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	RM 1.13m
Fonds propres	RM 83.49m
Total du passif	RM 40.20m
Total des actifs	RM 123.68m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Jiankun International Berhad's (KLSE:JIANKUN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 01

Here's Why We Think Jiankun International Berhad's (KLSE:JIANKUN) Statutory Earnings Might Be Conservative

Nov 29

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de JIANKUN ( MYR47.2M ) dépassent ses passifs à court terme ( MYR34.9M ).

Passif à long terme: Les actifs à court terme de JIANKUN ( MYR47.2M ) dépassent ses passifs à long terme ( MYR5.3M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de JIANKUN ( 2.3% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de JIANKUN a été réduit de 42.8% à 3.6% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: JIANKUN dispose de moins d'un an de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: JIANKUN dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 45.8 % chaque année

Jiankun International Berhad Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

First quarter 2025 earnings released: RM0.004 loss per share (vs RM0.017 loss in 1Q 2024)

New minor risk - Revenue size

Jiankun International Berhad, Annual General Meeting, Dec 10, 2024

New major risk - Market cap size

New minor risk - Share price stability

High number of new directors

First quarter 2024 earnings released: RM0.005 loss per share (vs RM0.005 loss in 1Q 2023)

Jiankun International Berhad Announces the Re- Designation of Dato' Saiful Nizam Bin Mohd Yusoff from President to Non-Independent Non-Executive Chairman

Full year 2023 earnings released: RM0.037 loss per share (vs RM0.069 loss in FY 2022)

Jiankun International Berhad Receives Writ of Summon and Statement of Claim by Messrs. James Monteiro

Third quarter 2023 earnings released: RM0.023 loss per share (vs RM0.01 loss in 3Q 2022)

Jiankun International Berhad announced that it expects to receive MYR 19 million in funding

Second quarter 2023 earnings released: RM0.005 loss per share (vs RM0.015 loss in 2Q 2022)

Jiankun International Berhad (KLSE:JIANKUN) entered into memorandum of understanding to acquire Dermaga Science & Health Sdn. Bhd. from Dermaga Utama Sdn. Bhd for RM 13 million.

First quarter 2023 earnings released: RM0.005 loss per share (vs RM0.001 profit in 1Q 2022)

Jiankun International Berhad Appoints Low Ven Sin as Company Secretary

Full year 2022 earnings released: RM0.078 loss per share (vs RM0.013 profit in FY 2021)

Jiankun International Berhad Announces Redesignation of Saiful Nizam Bin Mohd Yusoff as Executive President

Third quarter 2022 earnings released: RM0.009 loss per share (vs RM0.006 profit in 3Q 2021)

High number of new and inexperienced directors

Jiankun International Berhad Appoints Dato' Yong Chong Long as Non Independent and Non Executive Director

Jiankun International Berhad Announces Redesignation of DATO' SAIFUL NIZAM BIN MOHD YUSOFF, D.I.M.P from Executive Director to Executive Deputy Chairman

Second quarter 2022 earnings released: RM0.015 loss per share (vs RM0.003 profit in 2Q 2021)

Jiankun International Berhad Appoints Terence Cheah Eu Lee as Independent and Non Executive Director

First quarter 2022 earnings released: EPS: RM0.001 (vs RM0.002 in 1Q 2021)

Jiankun International Berhad Appoints P Ellango A/L Ponramu as Independent and Non Executive Chairman of Nomination Committee

High number of new and inexperienced directors

Jiankun International Berhad Appoints Thien Lee Mee as Company Secretary

Jiankun International Berhad Appoints Chew Huey Yen as Independent and Non Executive Member of Nomination Committee

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Jiankun International Berhad Announces Re-Designation of Dato' Ir Lim Siang Chai to Executive Deputy Chairman

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

First quarter 2021 earnings released: EPS RM0.002 (vs RM0.012 in 1Q 2020)

Independent Non-Executive Director has left the company

New 90-day low: RM0.43

Jiankun International Berhad's (KLSE:JIANKUN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: RM0.46

Jiankun International Berhad Appoints Encik Azmi Bin Osman as Chairman of Audit Committee

Jiankun International Berhad Announces Cessation of Encik Kamil Bin Abdul Rahman as Chairman of Nomination Committee

Jiankun International Berhad Announces the Appointment of Azmi Bin Osman as Independent and Non Executive and Independent Director

Jiankun International Berhad Announces Re-Designation of Lim Siang Chai from Executive Chairman to Executive Deputy Chairman

Jiankun International Berhad Announces Resignation of Datuk Lee Kian Seng as Non Executive Director

New 90-day high: RM0.58

Here's Why We Think Jiankun International Berhad's (KLSE:JIANKUN) Statutory Earnings Might Be Conservative

Third quarter 2020 earnings released: EPS RM0.016

New 90-day high: RM0.51

New 90-day high - RM0.47

First half earnings released

New 90-day high - RM0.46

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines